Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …

Now in its second edition, Health Communication: From Theory to Practice provides a
comprehensive introduction to theory, intervention design, current issues, and special topics …

During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …

Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

Existing clinical case definitions of pertussis are decades old and based largely on clinical
presentation in infants and children, yet an increasing burden is borne by adolescents and …

Bordetella pertussis–the cause of pertussis or whooping cough–is an exclusively human
pathogen. Disease elimination by vaccination should, therefore, be possible, but has proved …

The introduction of vaccination in the 1950s significantly reduced the morbidity and mortality
of pertussis. However, since the 1990s, a resurgence of pertussis has been observed in …

Pertussis causes nearly 300 000 deaths in children every year. Most deaths take place in
developing countries, but the infection remains a priority everywhere. Pertussis vaccination …

In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …